Long-term outcome and prognostic factors of single-dose Radioiodine Therapy in patients with Graves' disease.
CONCLUSIONS: In Taiwan, RAI therapy for GD patients reached an overall success rate of 70.9%, with a median dose of 7 mCi. This study identified patients with grade 3 goiter need a more aggressive RAI regimen.
PMID: 32057544 [PubMed - as supplied by publisher]
Source: J Formos Med Assoc - Category: General Medicine Authors: Yang YT, Chen JF, Tung SC, Kuo MC, Weng SW, Chou CK, Shen FC, Chang CM, Tsai CJ, Taso CF, Wang PW Tags: J Formos Med Assoc Source Type: research
More News: General Medicine | Hyperthyroidism | Hypothyroidism | Radioiodine Therapy | Study | Taiwan Health